EVALUATION OF THE EFFICACY OF TREATMENT OF “DRY EYE SYNDROME” AFTER LASIK OPERATION
Аннотация
Actuality. Dry eye syndrome (DES) is one of the most common chronic eye diseases. According to a number
of authors, the prevalence of this pathology among the adult population varies from 18 to 67% [1]. Significant
fluctuations in the prevalence of the disease are associated with a number of factors: the method of approach to
the diagnosis of DES, the choice of different age groups for research, race and climate in the regions of residence
of the studied populations [2]. Over the past 30 years, the incidence of dry eye syndrome has increased 4.5 times,
which is more than in men (69.7%). The incidence is 12% in patients under 50 years of age and 67% in adults
over 50 years of age [3]. There are many factors that cause dry autumn syndrome. In particular, the violation of
the radio frequency of the optical oceans of the eye and, most importantly, the misuse of modern technologies —
non-observance of hygiene of vision. In particular, one of the most observed complications after treatment with
the help of LASIK practice is the "dry eye" syndrome, which averages 45%. DES occurs in most patients who wear
contact lenses [4,5]. Often, due to the development of DES, patients are forced to refuse to wear contact lenses.
Currently, DES is registered in children and adolescents.
Библиографические ссылки
Егоров В. А. Особенности терапии синдрома сухого глаза // РМЖ. Клиническая офтальмология. 2018. Т. 18. № 3. С. 146–149. 2. Papas E. B., Ciolino J. B., Jacobs D. et al. The TFOS International Workshop on Contact Lens Discomfort: Report of the management and therapy subcommittee // Invest. Ophthal. Vis. Sci. 2017. Vol. 54. № 11.Р. 183–203.http://dx.doi.org/10.1016/j.jtos.2017.05.006
Бахритдинова Ф. А., Хайдарова Ф. А., Нарзикулова К. И., Набиева И. Ф. Эффективность препарата Кератроп при лечении синдрома сухогоглазау пациентов с сахарным диабетом// THE EYE ГЛАЗ.- 2020 4 (132) С. 36–41. https://doi.org/10.33791/2222–4408–2020–4–36–41
Опыт применения содержащей гепарин глазной мази у пациентов с синдромом «сухого глаза» // РМЖ. Клиническая офтальмология. 2019. № 1. 5. Jones L. et al. TFOS DEWS II Management and Therapy Report. The Ocular Surface 15 (2017) 575–628.http://dx.doi.org/10.1016/j.jtos.2017.05.006